A roadmap by the FDA for incorporating digital health technologies in clinical trials
Digital Health Global
MARCH 30, 2023
The FDA has announced several guidelines and plans to hold at least one public meeting on digital health technologies (DHTs) to be used in drug clinical trials by the end of the year. However, inconsistent DHT policies have been a major issue across review centres. Drug development process questions the reliability and accuracy of DHT products. FDA has formed a steering committee consisting of its drug, device, and biologics review centers to ensure consistency.
Let's personalize your content